首页> 外文OA文献 >Aplikasi Vaksin Streptococcus Agalactiae Untuk Pencegahan Penyakit Streptococcosis Pada Budidaya Ikan Nila (Oreochromis Niloticus) [Application of Streptococcus Agalactiae Vaccine to Prevent Streptococcosis on Tilapia Culture, Oreochromis Niloticus]
【2h】

Aplikasi Vaksin Streptococcus Agalactiae Untuk Pencegahan Penyakit Streptococcosis Pada Budidaya Ikan Nila (Oreochromis Niloticus) [Application of Streptococcus Agalactiae Vaccine to Prevent Streptococcosis on Tilapia Culture, Oreochromis Niloticus]

机译:无乳链球菌疫苗在预防尼罗罗非鱼链球菌中的应用[在罗非鱼养殖中,尼罗罗非鱼在预防链球菌病中的应用]。

摘要

The research with the aim to know the effectivity (yield gap) of the application of Streptococcus agalactiae vaccine (pure whole cell) in prevention of streptococcosis on tilapia (Oreochromis niloticus) culture has been carried out. The isolate of S.agalactiae – N14G was used as a master seed on vaccine production. Priming vaccination was administered by immersion method, and booster vaccination was taken th place two months latter by oral method. Challenge test at the lethal dose (LD50) against active bacteria was done at 14 days post booster vaccination, and observation was taken place for 14 days post artificial infection. The results of the research showed that the highest survival rate and relative percent survival (RPS) was found in group treated with Streptovac vaccine (S. agalactiae and A. hydrophila combination) (65.58% and 35.36%) followed by S. agalactiae vaccine (52.08% and 10.01%). The lowest survival rate was found in control group (46.75%). The result of confirmation effectivity of the vaccines by challenge test in the laboratory showed that the highest survival rate and relative percent survival (RPS) was found in S. agalactiae vaccine (50.00% dan 37.50%) followed by Streptovac vaccine (40.00% and 25.00%), and the lowest survival rate was found in control group (20.00%). Vaccination is better than the non vaccinated.
机译:为了了解无乳链球菌疫苗(纯全细胞)在罗非鱼(Oreochromis niloticus)培养物中预防链球菌的有效性(产量缺口)的研究。 agalactiae – N14G分离株用作疫苗生产的主要种子。通过浸没法进行初免疫苗接种,两个月后通过口服方法进行加强免疫。加强疫苗接种后第14天以致死剂量(LD50)对活性细菌进行攻击试验,人工感染后第14天进行观察。研究结果表明,在用链球菌疫苗(无乳链球菌和亲水性链球菌组合)治疗的组中,最高生存率和相对存活百分率(RPS)最高(分别为65.58%和35.36%),其次是无乳链球菌疫苗( 52.08%和10.01%)。对照组的最低存活率(46.75%)。在实验室中通过激发试验证实疫苗的有效性,结果表明,无乳链球菌疫苗(50.00%dan 37.50%),链球菌疫苗(40.00%和25.00)发现了最高的存活率和相对存活率(RPS)。 %),而对照组的最低存活率(20.00%)。接种疫苗要优于未接种疫苗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号